Corteva, Inc. (CTVA) stock
CTVANYSEAgricultural Production-CropsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 18/3081% below fair value
$9.19−2.95 (-24.30%)
Close on Nov 12, 2026Market cap $6.13BP/E 8.1Yield 7.62%
Corteva r&d expenses
Research and development expenses are spending on new products and technology.
Corteva's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.54B, up 7.9% year over year. For fiscal 2025 it was $1.47B, up 5.1% from the year before. The highest annual figure on record is $1.47B in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.47B | +5.1% |
| FY2024 | Dec 31, 2024 | $1.40B | +4.9% |
| FY2023 | Dec 31, 2023 | $1.34B | +10.0% |
| FY2022 | Dec 31, 2022 | $1.22B | +2.4% |
| FY2021 | Dec 31, 2021 | $1.19B | +3.9% |
| FY2020 | Dec 31, 2020 | $1.14B | -0.4% |
| FY2019 | Dec 31, 2019 | $1.15B | -15.4% |
| FY2018 | Dec 31, 2018 | $1.36B | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $397.00M | +13.1% |
| Q2 FY2026 | Jun 30, 2026 | $388.00M | +3.5% |
| Q1 FY2026 | Mar 31, 2026 | $341.00M | +1.8% |
| Q4 FY2025 | Dec 31, 2025 | $413.00M | +13.2% |
| Q3 FY2025 | Sep 30, 2025 | $351.00M | +0.9% |
| Q2 FY2025 | Jun 30, 2025 | $375.00M | +5.0% |
| Q1 FY2025 | Mar 31, 2025 | $335.00M | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | $365.00M | +2.2% |
| Q3 FY2024 | Sep 30, 2024 | $348.00M | +3.9% |
| Q2 FY2024 | Jun 30, 2024 | $357.00M | +8.5% |
| Q1 FY2024 | Mar 31, 2024 | $332.00M | +5.1% |
| Q4 FY2023 | Dec 31, 2023 | $357.00M | +5.0% |
| Q3 FY2023 | Sep 30, 2023 | $335.00M | +7.4% |
| Q2 FY2023 | Jun 30, 2023 | $329.00M | +11.1% |
| Q1 FY2023 | Mar 31, 2023 | $316.00M | +17.9% |
| Q4 FY2022 | Dec 31, 2022 | $340.00M | +7.6% |
| Q3 FY2022 | Sep 30, 2022 | $312.00M | +5.1% |
| Q2 FY2022 | Jun 30, 2022 | $296.00M | +1.0% |
| Q1 FY2022 | Mar 31, 2022 | $268.00M | -4.6% |
| Q4 FY2021 | Dec 31, 2021 | $316.00M | +3.6% |
| Q3 FY2021 | Sep 30, 2021 | $297.00M | +4.6% |
| Q2 FY2021 | Jun 30, 2021 | $293.00M | +7.3% |
| Q1 FY2021 | Mar 31, 2021 | $281.00M | +0.4% |
| Q4 FY2020 | Dec 31, 2020 | $305.00M | +5.2% |
| Q3 FY2020 | Sep 30, 2020 | $284.00M | -1.7% |
| Q2 FY2020 | Jun 30, 2020 | $273.00M | +1.5% |
| Q1 FY2020 | Mar 31, 2020 | $280.00M | -6.4% |
| Q4 FY2019 | Dec 31, 2019 | $290.00M | -15.9% |
| Q3 FY2019 | Sep 30, 2019 | $289.00M | -11.1% |
| Q2 FY2019 | Jun 30, 2019 | $269.00M | -24.0% |
| Q1 FY2019 | Mar 31, 2019 | $299.00M | -21.7% |
| Q4 FY2018 | Dec 31, 2018 | $345.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $325.00M | – |
| Q2 FY2018 | Jun 30, 2018 | $354.00M | – |
| Q1 FY2018 | Mar 31, 2018 | $382.00M | – |
See a number that looks wrong?